These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14765944)

  • 1. Disease modification in multiple sclerosis.
    Sheerani M
    J Pak Med Assoc; 2003 Dec; 53(12):612-5. PubMed ID: 14765944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current methods of the multiple sclerosis treatment].
    Kovalenko PA; Shamanskiĭ SV; Baziĭ NI
    Voen Med Zh; 2001 Oct; 322(10):45-52. PubMed ID: 11764483
    [No Abstract]   [Full Text] [Related]  

  • 3. New treatments for multiple sclerosis.
    Kilpatrick TJ; Soilu-Hänninen M
    Aust N Z J Med; 1999 Dec; 29(6):801-10. PubMed ID: 10677125
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry
    Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment modification in multiple sclerosis: classifications, alternatives, and the outcomes].
    Cendrowski W
    Neurol Neurochir Pol; 2007; 41(4):365-8. PubMed ID: 18027457
    [No Abstract]   [Full Text] [Related]  

  • 6. The new era of multiple sclerosis therapy.
    Olsson T
    J Intern Med; 2014 Apr; 275(4):382-6. PubMed ID: 24433367
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of multiple sclerosis.
    Rudick RA; Cohen JA; Weinstock-Guttman B; Kinkel RP; Ransohoff RM
    N Engl J Med; 1997 Nov; 337(22):1604-11. PubMed ID: 9371858
    [No Abstract]   [Full Text] [Related]  

  • 8. [Review of the therapy of multiple sclerosis].
    De Rosa A; Puccini A; De Martino V
    Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
    [No Abstract]   [Full Text] [Related]  

  • 9. [What's new in multiple sclerosis therapy?].
    Vaney C; Derfuss T
    Rev Med Suisse; 2013 Jan; 9(371):285-7. PubMed ID: 23451607
    [No Abstract]   [Full Text] [Related]  

  • 10. Medications used in the treatment of multiple sclerosis.
    Schapiro RT
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):437-46, ix. PubMed ID: 10370939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seeing injectable ms therapies differently: they are more similar than different.
    Johnson KP; Fox RJ; Arnold DL
    Neurology; 2010 Feb; 74(8):702. PubMed ID: 20177129
    [No Abstract]   [Full Text] [Related]  

  • 12. Glatiramer: a second look. With longer follow-up: still no proven benefit in multiple sclerosis.
    Prescrire Int; 2009 Dec; 18(104):252. PubMed ID: 20025092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and MRI effects of Glatirameracetate].
    Nervenarzt; 1999 Aug; 70(8 Suppl):1-8. PubMed ID: 10511871
    [No Abstract]   [Full Text] [Related]  

  • 14. Grey matter atrophy in patients suffering from multiple sclerosis.
    Kincses ZT; Tóth E; Bankó N; Veréb D; Szabó N; Csete G; Faragó P; Király A; Bencsik K; Vécsei L
    Ideggyogy Sz; 2014 Sep; 67(9-10):293-300. PubMed ID: 25518257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reflections on the multiple sclerosis and its treatment].
    Woyciechowska J
    Neurol Neurochir Pol; 2003; 37(6):1343-4. PubMed ID: 15174246
    [No Abstract]   [Full Text] [Related]  

  • 17. A changing treatment landscape for multiple sclerosis: challenges and opportunities.
    Piehl F
    J Intern Med; 2014 Apr; 275(4):364-81. PubMed ID: 24444084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.
    Kalincik T; Horakova D; Dolezal O; Krasensky J; Vaneckova M; Seidl Z; Havrdova E
    Clin Neurol Neurosurg; 2012 Sep; 114(7):940-6. PubMed ID: 22402204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR images.
    Barkhof F; van Waesberghe JH; Uitdehaag BM; Polman CH
    Ann Neurol; 1997 Dec; 42(6):982. PubMed ID: 9403493
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic strategies for multiple sclerosis--update 2008].
    Kanter vI; Mäurer M
    MMW Fortschr Med; 2008 Jun; 150(23):42-5. PubMed ID: 18575371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.